Izzah Athirah Rosli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Izzah Athirah Rosli has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Nor Asiah Muhamad
Sector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Shah Alam, Selangor, Malaysia
13 shared publications - Nur Hasnah Maamor
Sector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Shah Alam, Selangor, Malaysia
13 shared publications - Fatin Norhasny Leman
Sector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia
12 shared publications - Norliza Chemi
Department of Psychiatry and Mental Health, Kajang Hospital, Ministry of Health, Kajang, Malaysia
6 shared publications - Nurashikin Ibrahim
National Centre of Exellence for Mental Health, Ministry of Health, Cyberjaya, Malaysia
6 shared publications - Nurul Hidayah Jamalluddin
Sector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia
6 shared publications
Latest Publications
- Open Access
- 22 April 2026
- Published by MDPI AG in Atmosphere
- Vol. 17 (5) , 433
Volatile Organic Compound Exposure and Neurodevelopmental Outcomes in Children: A Systematic Review and Meta-Analysis
Volatile organic compounds (VOCs) are ubiquitous pollutants, and exposure from in utero through childhood may impair neurodevelopment. However, compound-specific risks remain unclear. This systematic review and meta-analysis examined associations between VOC exposure and child neurodevelopmental outcomes. A systematic search of PubMed, Scopus, and Embase was conducted until August 2025, yielding 1213 records. Quality assessment was performed using the Newcastle–Ottawa Scale and risk of bias using the ROBINS-E tool. Pooled odds ratios (ORs) were calculated using random-effects models, with heterogeneity evaluated via I2 statistics. Subgroup analyses explored for study design, exposure timing, and country income level. Twenty-eight studies were included in the final analysis. Of the 18 VOCs analyzed, five compounds, propionaldehyde (pooled OR = 1.84; 95% CI 1.19–2.49), styrene (pooled OR = 1.69; 95% CI 1.30–2.21), vinyl chloride (pooled OR = 1.53; 95% CI 1.24–1.89), acrolein (pooled OR = 1.48; 95% CI 1.08–2.04), and trichloroethylene (OR = 1.21; 95% CI 1.04–1.41), demonstrated statistically significant adverse associations with neurodevelopment. Benzene showed borderline significance. Heterogeneity ranged from 0–47%. Subgroup analyses identified significant effect modification for 1,3-butadiene by study design and exposure timing and higher pooled estimates for ethylbenzene in high-income countries.
- 22 April 2026
- Published by MDPI AG in Atmosphere
- Vol. 17 (5) , 433
Open AccessVolatile Organic Compound Exposure and Neurodevelopmental Outcomes in Children: A Systematic Review and Meta-Analysis
Volatile organic compounds (VOCs) are ubiquitous pollutants, and exposure from in utero through childhood may impair neurodevelopment. However, compound-specific risks remain unclear. This systematic review and meta-analysis examined associations between VOC exposure and child neurodevelopmental outcomes. A systematic search of PubMed, Scopus, and Embase was conducted until August 2025, yielding 1213 records. Quality assessment was performed using the Newcastle–Ottawa Scale and risk of bias using the ROBINS-E tool. Pooled odds ratios (ORs) were calculated using random-effects models, with heterogeneity evaluated via I2 statistics. Subgroup analyses explored for study design, exposure timing, and country income level. Twenty-eight studies were included in the final analysis. Of the 18 VOCs analyzed, five compounds, propionaldehyde (pooled OR = 1.84; 95% CI 1.19–2.49), styrene (pooled OR = 1.69; 95% CI 1.30–2.21), vinyl chloride (pooled OR = 1.53; 95% CI 1.24–1.89), acrolein (pooled OR = 1.48; 95% CI 1.08–2.04), and trichloroethylene (OR = 1.21; 95% CI 1.04–1.41), demonstrated statistically significant adverse associations with neurodevelopment. Benzene showed borderline significance. Heterogeneity ranged from 0–47%. Subgroup analyses identified significant effect modification for 1,3-butadiene by study design and exposure timing and higher pooled estimates for ethylbenzene in high-income countries.
- Open Access
- 12 February 2026
- Published by Elsevier in SSRN Electronic Journal
Empowering Low-Income Communities to Combat Dengue through Local Advocacy: Evaluation of the B.O.L.E.H. Initiative in Kuala Lumpur, Malaysia
Background: Malaysia continues to face rising dengue incidence, particularly in high-density low-income housing where structural and behavioural vulnerabilities converge. This study evaluated the B.O.L.E.H. (B40 Communities Organising Local Solutions for Environmental Health) model—a multistage, community-governed intervention designed to strengthen resident capacity, improve knowledge, attitudes, and practices (KAP), and assess its association with trends in dengue incidence.Methods: A quasi-experimental pre–post design was implemented across four Program Perumahan Rakyat (PPR) communities in Lembah Pantai, Kuala Lumpur. Stage 1 involved advocate training and baseline KAP assessment at PPR Sri Pantai, followed by deployment of trained advocates to three neighbouring PPRs for Stage 2 implementation. The intervention included educational materials, lift-lobby posters, WhatsApp reminders, and champion-led engagement, which were evaluated via mosquito ovitraps and structured checklists to measure changes in environmental risk and community participation. KAP surveys were conducted at baseline, midline, and post-intervention. Monthly dengue incidence was obtained from national surveillance and analysed using negative binomial Generalised Estimating Equations with a log-population offset to estimate group, time, and interaction effects.Findings: Intervention communities demonstrated significant improvements in knowledge and practice (p<0·001). Monthly dengue incidence declined 5% per month in intervention localities (IRR 0·95, 0·92–0·98; p=0·004). Control communities experienced more than three-fold higher incidence overall (IRR 3·11, 2·56–3·78; p<0·0001) and a significantly faster increase in incidence over time (time×group IRR 1·05, 1·04–1·06; p<0·0001). In a separate predictors model, at the PPR level, higher mean knowledge scores were associated with lower dengue incidence (IRR 0·42 per one-point increase in mean knowledge; 95% CI 0·36–0·50).Interpretation: Embedding resident-led micro-governance through floor-level leadership, routine monitoring, and recognition systems was associated with sustained preventive action and a more favourable dengue-incidence trajectory. Given the non-randomised design, the small number of PPRs, baseline socioeconomic differences, and the ecological nature of the predictors analysis, these findings cannot establish causality. However, they suggest that the B.O.L.E.H. model could usefully complement national dengue-control strategies as a community-governed layer in high-risk urban settings.
- 12 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEmpowering Low-Income Communities to Combat Dengue through Local Advocacy: Evaluation of the B.O.L.E.H. Initiative in Kuala Lumpur, Malaysia
Background: Malaysia continues to face rising dengue incidence, particularly in high-density low-income housing where structural and behavioural vulnerabilities converge. This study evaluated the B.O.L.E.H. (B40 Communities Organising Local Solutions for Environmental Health) model—a multistage, community-governed intervention designed to strengthen resident capacity, improve knowledge, attitudes, and practices (KAP), and assess its association with trends in dengue incidence.Methods: A quasi-experimental pre–post design was implemented across four Program Perumahan Rakyat (PPR) communities in Lembah Pantai, Kuala Lumpur. Stage 1 involved advocate training and baseline KAP assessment at PPR Sri Pantai, followed by deployment of trained advocates to three neighbouring PPRs for Stage 2 implementation. The intervention included educational materials, lift-lobby posters, WhatsApp reminders, and champion-led engagement, which were evaluated via mosquito ovitraps and structured checklists to measure changes in environmental risk and community participation. KAP surveys were conducted at baseline, midline, and post-intervention. Monthly dengue incidence was obtained from national surveillance and analysed using negative binomial Generalised Estimating Equations with a log-population offset to estimate group, time, and interaction effects.Findings: Intervention communities demonstrated significant improvements in knowledge and practice (p<0·001). Monthly dengue incidence declined 5% per month in intervention localities (IRR 0·95, 0·92–0·98; p=0·004). Control communities experienced more than three-fold higher incidence overall (IRR 3·11, 2·56–3·78; p<0·0001) and a significantly faster increase in incidence over time (time×group IRR 1·05, 1·04–1·06; p<0·0001). In a separate predictors model, at the PPR level, higher mean knowledge scores were associated with lower dengue incidence (IRR 0·42 per one-point increase in mean knowledge; 95% CI 0·36–0·50).Interpretation: Embedding resident-led micro-governance through floor-level leadership, routine monitoring, and recognition systems was associated with sustained preventive action and a more favourable dengue-incidence trajectory. Given the non-randomised design, the small number of PPRs, baseline socioeconomic differences, and the ecological nature of the predictors analysis, these findings cannot establish causality. However, they suggest that the B.O.L.E.H. model could usefully complement national dengue-control strategies as a community-governed layer in high-risk urban settings.
- Open Access
- 12 February 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e71620
Donor Risk Factors Affecting Graft Survival in Pediatric Kidney Transplants: Protocol for a Systematic Review and Meta-Analysis
Background: Pediatric patients with end-stage kidney disease require kidney transplants (KTs) throughout their lifetime. Long-term graft survival is dependent on multiple factors, which are broadly categorized as donor- and recipient-related factors. Advances in transplant care and changes in donor population demographics necessitate an updated analysis on donor risk factors to guide clinical decision-making. Objective: In this systematic review and meta-analysis, we will focus on the impact of donor factors on graft survival in pediatric KT, excluding transplants from donation after circulatory death as the latter are less common in children. Methods: This review encompasses studies reporting donor-related risk factors for graft survival in pediatric KT, including age, size, comorbidities, and ethnicity for living and deceased donors, as well as the cause of death and length of hospitalization for deceased donors. The literature search will use the following databases: PubMed, Scopus, Web of Science, Embase, and Cochrane. Two independent reviewers will select studies and assess their quality. Pooled estimates of relevant factors will be computed via a random-effects model using the Stata/BE (version 19) software. Depending on data availability, subgroup analyses will be conducted based on donor type (living vs deceased). The reporting of findings will adhere to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Results: The search and screening for the systematic literature review are anticipated to be finished in June 2026. Data extraction, quality appraisal, and subsequent data synthesis will begin in July 2026. The review is expected to be completed by October 2026, and the study results will be published in 2027. Conclusions: Our review will provide a comprehensive synthesis of the available evidence on kidney donor risk factors impacting graft survival in pediatric KT. The results of this review could provide valuable insights for clinical decisions, policy development, and ongoing efforts to improve outcomes for children with end-stage kidney disease requiring KT.
- 12 February 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e71620
Open AccessDonor Risk Factors Affecting Graft Survival in Pediatric Kidney Transplants: Protocol for a Systematic Review and Meta-Analysis
Background: Pediatric patients with end-stage kidney disease require kidney transplants (KTs) throughout their lifetime. Long-term graft survival is dependent on multiple factors, which are broadly categorized as donor- and recipient-related factors. Advances in transplant care and changes in donor population demographics necessitate an updated analysis on donor risk factors to guide clinical decision-making. Objective: In this systematic review and meta-analysis, we will focus on the impact of donor factors on graft survival in pediatric KT, excluding transplants from donation after circulatory death as the latter are less common in children. Methods: This review encompasses studies reporting donor-related risk factors for graft survival in pediatric KT, including age, size, comorbidities, and ethnicity for living and deceased donors, as well as the cause of death and length of hospitalization for deceased donors. The literature search will use the following databases: PubMed, Scopus, Web of Science, Embase, and Cochrane. Two independent reviewers will select studies and assess their quality. Pooled estimates of relevant factors will be computed via a random-effects model using the Stata/BE (version 19) software. Depending on data availability, subgroup analyses will be conducted based on donor type (living vs deceased). The reporting of findings will adhere to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Results: The search and screening for the systematic literature review are anticipated to be finished in June 2026. Data extraction, quality appraisal, and subsequent data synthesis will begin in July 2026. The review is expected to be completed by October 2026, and the study results will be published in 2027. Conclusions: Our review will provide a comprehensive synthesis of the available evidence on kidney donor risk factors impacting graft survival in pediatric KT. The results of this review could provide valuable insights for clinical decisions, policy development, and ongoing efforts to improve outcomes for children with end-stage kidney disease requiring KT.
- Open Access
- 2 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e63663
Prevalence and Factors Associated With Depression Among Antenatal and Postnatal Women Attending Government Health Clinics in Selangor, Malaysia: Protocol for a Cross-Sectional Study
Background: Maternal mental health concerns either during pregnancy or the postpartum period are a public health challenge. Depression, anxiety, and stress can lead to poorer outcomes in the antenatal and postpartum periods. There is evidence that the effect of stress, anxiety, and depression during pregnancy negatively affects fetal neurodevelopment and children’s developmental outcomes. Early diagnosis can improve treatment outcomes and prevent negative impacts on the mother and baby. Identifying risk factors, such as age, socioeconomic status, mental health history, and family dysfunction, and clinical manifestations are important for public health programs. Objective: This study aims to determine the prevalence of depression and associated risk factors among antenatal and postnatal women attending government health clinics in Selangor. Methods: A multicenter cross-sectional study will be conducted among antenatal and postnatal women attending government health clinics (Klinik Kesihatan) in Selangor, Malaysia, from August 1, 2024, to December 31, 2026. We will perform a simple random sampling in all 9 districts in Selangor to select 1 government health clinic in each district. The inclusion criteria for this study are women aged 18 years and older who are either pregnant or delivered a newborn or stillborn child within the preceding 6 weeks. We will use a published screening tool (Edinburgh Postnatal Depression Scale) to determine the level of depression among antenatal and postnatal women. We will also collect data on sociodemographic characteristics, obstetric factors, and psychosocial support. Results: We will obtain ethics approval from the relevant ethics boards prior to data collection. Data will be analyzed using SPSS version 26.0 (IBM Corporation) and we will conduct a descriptive analysis to determine the prevalence of depression. We will calculate the level of depression among antenatal and postnatal women and score it based on a previous study conducted in Malaysia, with a score of ≥12 indicating the presence of depression. The association between depression and risk factors will be determined by multiple logistic regression analysis. P values less than .05 will be considered statistically significant. Conclusions: Depression is one of the mental health complications that may arise following childbirth. Therefore, the findings of this study on the prevalence and associated risk factors of depression among antenatal and postnatal women in Selangor may help women address this challenge and improve maternal mental health during pregnancy and after birth. International Registered Report Identifier (IRRID): PRR1-10.2196/63663
- 2 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e63663
Open AccessPrevalence and Factors Associated With Depression Among Antenatal and Postnatal Women Attending Government Health Clinics in Selangor, Malaysia: Protocol for a Cross-Sectional Study
Background: Maternal mental health concerns either during pregnancy or the postpartum period are a public health challenge. Depression, anxiety, and stress can lead to poorer outcomes in the antenatal and postpartum periods. There is evidence that the effect of stress, anxiety, and depression during pregnancy negatively affects fetal neurodevelopment and children’s developmental outcomes. Early diagnosis can improve treatment outcomes and prevent negative impacts on the mother and baby. Identifying risk factors, such as age, socioeconomic status, mental health history, and family dysfunction, and clinical manifestations are important for public health programs. Objective: This study aims to determine the prevalence of depression and associated risk factors among antenatal and postnatal women attending government health clinics in Selangor. Methods: A multicenter cross-sectional study will be conducted among antenatal and postnatal women attending government health clinics (Klinik Kesihatan) in Selangor, Malaysia, from August 1, 2024, to December 31, 2026. We will perform a simple random sampling in all 9 districts in Selangor to select 1 government health clinic in each district. The inclusion criteria for this study are women aged 18 years and older who are either pregnant or delivered a newborn or stillborn child within the preceding 6 weeks. We will use a published screening tool (Edinburgh Postnatal Depression Scale) to determine the level of depression among antenatal and postnatal women. We will also collect data on sociodemographic characteristics, obstetric factors, and psychosocial support. Results: We will obtain ethics approval from the relevant ethics boards prior to data collection. Data will be analyzed using SPSS version 26.0 (IBM Corporation) and we will conduct a descriptive analysis to determine the prevalence of depression. We will calculate the level of depression among antenatal and postnatal women and score it based on a previous study conducted in Malaysia, with a score of ≥12 indicating the presence of depression. The association between depression and risk factors will be determined by multiple logistic regression analysis. P values less than .05 will be considered statistically significant. Conclusions: Depression is one of the mental health complications that may arise following childbirth. Therefore, the findings of this study on the prevalence and associated risk factors of depression among antenatal and postnatal women in Selangor may help women address this challenge and improve maternal mental health during pregnancy and after birth. International Registered Report Identifier (IRRID): PRR1-10.2196/63663
- Open Access
- 17 September 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e67059
Prevalence and Associated Risk Factors of Self-Harm Among Health Care Workers: Protocol for Systematic Review and Meta-Analysis
Background: Self-harm is a major public health concern, with prevalence increasing worldwide, particularly after the COVID-19 pandemic and associated lockdown restrictions. Health care workers (HCWs) face various challenges, such as pressures of social and familial responsibilities, a lack of integration within the profession, heavier workload, bullying at the workplace, and limited support in the workplace, that impact their mental health and often lead to self-harm. Objective: We aim to synthesize the evidence on the pooled prevalence of self-harm worldwide and identify risk factors for self-harm among HCWs. Methods: We will conduct a systematic review of observational and experimental studies that investigated the overall prevalence of self-harm among HCWs. We will search the PubMed, PsycINFO, Embase, and CINAHL databases for eligible articles from inception until March 2025 using specific search terms developed using the population, exposure, comparison, and outcome framework. Study selection and reporting will follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and the Meta-Analysis of Observational Studies in Epidemiology guidelines. We will contact the corresponding author via email if the required data are not available in the article. After completing the article search, duplicate records will be removed. Titles and abstracts will then be screened according to the inclusion and exclusion criteria, followed by retrieval of the full texts for detailed screening. All the required data for the review, such as names of authors, publication year, prevalence of self-harm, type of profession, associated risk factors to self-harm, and others, will be extracted using a standardized data extraction form. The quality of the studies will be assessed using the Joanna Briggs Institute guidelines based on the study design. Random-effects meta-analysis will be used to derive the pooled prevalence using Stata (version 17.0) software. We will conduct a subgroup meta-analysis on sex, regions, and the type of profession (physicians or nurses). We will also examine the association of risk factors of self-harm with sociodemographic factors to observe their relationship. Both analyses will be performed using RevMan software. Publication bias will be examined using the funnel plot and Egger test. Results: Data analysis is expected to be completed by August 2025, and manuscript preparation is expected to be completed by October 2025. This review is expected to be completed and published by January 2026. Conclusions: We will provide a comprehensive synthesis of the overall prevalence of self-harm among HCWs. We will also provide important information to develop effective strategies for preventing and managing self-harm among HCWs. Trial Registration: PROSPERO CRD42024581791; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024581791 International Registered Report Identifier (IRRID): PRR1-10.2196/67059
- 17 September 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e67059
Open AccessPrevalence and Associated Risk Factors of Self-Harm Among Health Care Workers: Protocol for Systematic Review and Meta-Analysis
Background: Self-harm is a major public health concern, with prevalence increasing worldwide, particularly after the COVID-19 pandemic and associated lockdown restrictions. Health care workers (HCWs) face various challenges, such as pressures of social and familial responsibilities, a lack of integration within the profession, heavier workload, bullying at the workplace, and limited support in the workplace, that impact their mental health and often lead to self-harm. Objective: We aim to synthesize the evidence on the pooled prevalence of self-harm worldwide and identify risk factors for self-harm among HCWs. Methods: We will conduct a systematic review of observational and experimental studies that investigated the overall prevalence of self-harm among HCWs. We will search the PubMed, PsycINFO, Embase, and CINAHL databases for eligible articles from inception until March 2025 using specific search terms developed using the population, exposure, comparison, and outcome framework. Study selection and reporting will follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and the Meta-Analysis of Observational Studies in Epidemiology guidelines. We will contact the corresponding author via email if the required data are not available in the article. After completing the article search, duplicate records will be removed. Titles and abstracts will then be screened according to the inclusion and exclusion criteria, followed by retrieval of the full texts for detailed screening. All the required data for the review, such as names of authors, publication year, prevalence of self-harm, type of profession, associated risk factors to self-harm, and others, will be extracted using a standardized data extraction form. The quality of the studies will be assessed using the Joanna Briggs Institute guidelines based on the study design. Random-effects meta-analysis will be used to derive the pooled prevalence using Stata (version 17.0) software. We will conduct a subgroup meta-analysis on sex, regions, and the type of profession (physicians or nurses). We will also examine the association of risk factors of self-harm with sociodemographic factors to observe their relationship. Both analyses will be performed using RevMan software. Publication bias will be examined using the funnel plot and Egger test. Results: Data analysis is expected to be completed by August 2025, and manuscript preparation is expected to be completed by October 2025. This review is expected to be completed and published by January 2026. Conclusions: We will provide a comprehensive synthesis of the overall prevalence of self-harm among HCWs. We will also provide important information to develop effective strategies for preventing and managing self-harm among HCWs. Trial Registration: PROSPERO CRD42024581791; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024581791 International Registered Report Identifier (IRRID): PRR1-10.2196/67059
- Open Access
- 7 August 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e64101
Use of Naltrexone for Patients With Stimulant Use Disorder in Malaysia: Protocol for a Retrospective Cohort Study
Background: Naltrexone is an opioid receptor antagonist. Naltrexone is used to block the euphoric and sedative effects of drugs such as heroin, codeine, and morphine. The medication helps to bind and block opioid receptors to decrease opioid cravings. In Malaysia, naltrexone has been used for maintenance treatments for heroin and alcohol since 1996. However, since 2011, naltrexone has been used as an off-label stimulant use disorder (StUD) treatment to achieve abstinence. Objective: This study aims to determine the abstinence among StUD and non-StUD patients treated and without naltrexone. Methods: We will conduct a retrospective cohort study on the effect of naltrexone or treatment as usual (TAU) by examining the data for both StUD and non-StUD patients. We will use patients’ clinical records from the hospital registry. All adult patients (aged 18-65 years) diagnosed with StUD or other substance use disorders who were treated with naltrexone and standard care from January 1, 2011, to December 31, 2023, will be screened. All StUD and non-StUD patients who were offered the naltrexone treatment or TAU at the beginning of treatment will be recruited. All data will be extracted using a standardized data extraction form. Descriptive analysis will be performed to describe the distribution of patient characteristics, sociodemographic profiles, and percentages of abstinence and treatment retention. We will conduct univariable analysis to determine the association of stimulant abstinence and treatment retention between naltrexone and TAU among both StUD and non-StUD patients. All significant independent variables will be further analyzed using a cross-sectional time series method for categorical variables. Results: Recruitment began in July 2025. Data analysis will begin after completing data collection, planned for January 2026. Conclusions: The expected main outcome of this study is to observe the significant associations of stimulant use abstinence and treatment retention between TAU and naltrexone among StUD and non-StUD patients. The findings from this study may provide preliminary evidence regarding the use of naltrexone in treating StUD. Currently, there is no specific medication to treat amphetamine or methamphetamine use disorder. The effect of naltrexone with psychosocial interventions for StUD is unclear. Public health approaches recognize the multifaceted nature of substance misuse and focus on addressing the myriad individual, environmental, and social factors that contribute to StUD. International Registered Report Identifier (IRRID): PRR1-10.2196/64101
- 7 August 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e64101
Open AccessUse of Naltrexone for Patients With Stimulant Use Disorder in Malaysia: Protocol for a Retrospective Cohort Study
Background: Naltrexone is an opioid receptor antagonist. Naltrexone is used to block the euphoric and sedative effects of drugs such as heroin, codeine, and morphine. The medication helps to bind and block opioid receptors to decrease opioid cravings. In Malaysia, naltrexone has been used for maintenance treatments for heroin and alcohol since 1996. However, since 2011, naltrexone has been used as an off-label stimulant use disorder (StUD) treatment to achieve abstinence. Objective: This study aims to determine the abstinence among StUD and non-StUD patients treated and without naltrexone. Methods: We will conduct a retrospective cohort study on the effect of naltrexone or treatment as usual (TAU) by examining the data for both StUD and non-StUD patients. We will use patients’ clinical records from the hospital registry. All adult patients (aged 18-65 years) diagnosed with StUD or other substance use disorders who were treated with naltrexone and standard care from January 1, 2011, to December 31, 2023, will be screened. All StUD and non-StUD patients who were offered the naltrexone treatment or TAU at the beginning of treatment will be recruited. All data will be extracted using a standardized data extraction form. Descriptive analysis will be performed to describe the distribution of patient characteristics, sociodemographic profiles, and percentages of abstinence and treatment retention. We will conduct univariable analysis to determine the association of stimulant abstinence and treatment retention between naltrexone and TAU among both StUD and non-StUD patients. All significant independent variables will be further analyzed using a cross-sectional time series method for categorical variables. Results: Recruitment began in July 2025. Data analysis will begin after completing data collection, planned for January 2026. Conclusions: The expected main outcome of this study is to observe the significant associations of stimulant use abstinence and treatment retention between TAU and naltrexone among StUD and non-StUD patients. The findings from this study may provide preliminary evidence regarding the use of naltrexone in treating StUD. Currently, there is no specific medication to treat amphetamine or methamphetamine use disorder. The effect of naltrexone with psychosocial interventions for StUD is unclear. Public health approaches recognize the multifaceted nature of substance misuse and focus on addressing the myriad individual, environmental, and social factors that contribute to StUD. International Registered Report Identifier (IRRID): PRR1-10.2196/64101
- Open Access
- 22 January 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Donor Risk Factors Affecting Graft Survival in Pediatric Kidney Transplantations: Protocol for a Systematic Review and Meta-analysis (Preprint)
BACKGROUND Pediatric patients with end-stage kidney disease require kidney transplants (KT) throughout their lifetime. Long-term graft survival is dependent on multiple factors which are broadly categorized as donor and recipient related factors. Advances in transplant care and changes in donor population demographics necessitate an updated analysis on donor risk factors to guide clinical decision making. OBJECTIVE In this systematic review/meta-analysis, we will focus on the impact of donor factors on graft survival in pediatric KT, excluding transplants from donation after circulatory death as the latter are less common in children. METHODS This review encompasses studies reporting donor-related risk factors for graft survival in pediatric KT, including age, size, comorbidities, and ethnicity for living and deceased donors, also the cause of death and length of hospitalization for deceased donors. The literature search will use databases including PubMed, Scopus, Web of Science, Embase, and Cochrane. Two independent reviewers will select studies and assess their quality. Pooled estimates of relevant factors will be computed via a random-effects model using Stata/BE 18 software. Depending on data availability, the subgroup analyses will be conducted based on factors such as donor type (living versus deceased) and age group. The reporting of findings will adhere to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. RESULTS The search and screening for the systematic literature review are anticipated to be finished in August 2025. Data extraction, quality appraisal, and subsequent data synthesis will begin in September 2025. The review is expected to be completed by April 2026, and the study results will be published in 2026. CONCLUSIONS Our review will provide a comprehensive synthesis of the available evidence on kidney donor risk factors impacting graft survival in pediatric KT. The results of this review could provide valuable insights for clinical decisions, policy development, and ongoing efforts to improve outcomes for children with end-stage kidney disease requiring KT. CLINICALTRIAL PROSPERO CRD42024500442. https://www.crd.york. ac.uk/prospero/display_record.php?ID=CRD42024500442
- 22 January 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDonor Risk Factors Affecting Graft Survival in Pediatric Kidney Transplantations: Protocol for a Systematic Review and Meta-analysis (Preprint)
BACKGROUND Pediatric patients with end-stage kidney disease require kidney transplants (KT) throughout their lifetime. Long-term graft survival is dependent on multiple factors which are broadly categorized as donor and recipient related factors. Advances in transplant care and changes in donor population demographics necessitate an updated analysis on donor risk factors to guide clinical decision making. OBJECTIVE In this systematic review/meta-analysis, we will focus on the impact of donor factors on graft survival in pediatric KT, excluding transplants from donation after circulatory death as the latter are less common in children. METHODS This review encompasses studies reporting donor-related risk factors for graft survival in pediatric KT, including age, size, comorbidities, and ethnicity for living and deceased donors, also the cause of death and length of hospitalization for deceased donors. The literature search will use databases including PubMed, Scopus, Web of Science, Embase, and Cochrane. Two independent reviewers will select studies and assess their quality. Pooled estimates of relevant factors will be computed via a random-effects model using Stata/BE 18 software. Depending on data availability, the subgroup analyses will be conducted based on factors such as donor type (living versus deceased) and age group. The reporting of findings will adhere to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. RESULTS The search and screening for the systematic literature review are anticipated to be finished in August 2025. Data extraction, quality appraisal, and subsequent data synthesis will begin in September 2025. The review is expected to be completed by April 2026, and the study results will be published in 2026. CONCLUSIONS Our review will provide a comprehensive synthesis of the available evidence on kidney donor risk factors impacting graft survival in pediatric KT. The results of this review could provide valuable insights for clinical decisions, policy development, and ongoing efforts to improve outcomes for children with end-stage kidney disease requiring KT. CLINICALTRIAL PROSPERO CRD42024500442. https://www.crd.york. ac.uk/prospero/display_record.php?ID=CRD42024500442
- Open Access
- 24 October 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (10) , e0302379
Prevalence of caregiver hesitancy for vaccinations in children and its associated factors: A systematic review and meta-analysis
This review aimed to systematically compare and pool the prevalence of all the known evidence on caregiver hesitancy and to describe the factors influencing vaccine hesitancy among caregiver worldwide such as COVID-19, MMR, Influenza, HPV and others. We searched article from few electronic databases (PubMed, CENTRAL, ProQuest, and Web of Science) from inception to August 2023 using specific keywords for example caregiver, parents, prevalence, factor, hesitancy, and others. We included population-based studies that reported the prevalence of caregiver hesitancy. We used random-effects meta-analyses for pool prevalence estimates of caregiver hesitancy. A total of 765 studies met our inclusion criteria, containing data on 38,210,589 caregivers from seven regions across the globe. Overall or pool prevalence of vaccine hesitancy among caregiver is 25.0% (95% CI: 0.22–0.27, I2 = 99.91%, p = 0.001). Based on the evidence gathered, vaccine hesitancy was found to be religious sentiments, personal beliefs, perceived safety concerns, and a desire for more information from healthcare providers, along with factors related to availability, accessibility, affordability, and acceptability of vaccinations. Vaccine safety and efficiency have been identified as the main factor for caregiver vaccine hesitancy globally with a prevalence of 91.4%. Trial registration PROSPERO registration number: CRD42022331629. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022331629.
- 24 October 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (10) , e0302379
Open AccessPrevalence of caregiver hesitancy for vaccinations in children and its associated factors: A systematic review and meta-analysis
This review aimed to systematically compare and pool the prevalence of all the known evidence on caregiver hesitancy and to describe the factors influencing vaccine hesitancy among caregiver worldwide such as COVID-19, MMR, Influenza, HPV and others. We searched article from few electronic databases (PubMed, CENTRAL, ProQuest, and Web of Science) from inception to August 2023 using specific keywords for example caregiver, parents, prevalence, factor, hesitancy, and others. We included population-based studies that reported the prevalence of caregiver hesitancy. We used random-effects meta-analyses for pool prevalence estimates of caregiver hesitancy. A total of 765 studies met our inclusion criteria, containing data on 38,210,589 caregivers from seven regions across the globe. Overall or pool prevalence of vaccine hesitancy among caregiver is 25.0% (95% CI: 0.22–0.27, I2 = 99.91%, p = 0.001). Based on the evidence gathered, vaccine hesitancy was found to be religious sentiments, personal beliefs, perceived safety concerns, and a desire for more information from healthcare providers, along with factors related to availability, accessibility, affordability, and acceptability of vaccinations. Vaccine safety and efficiency have been identified as the main factor for caregiver vaccine hesitancy globally with a prevalence of 91.4%. Trial registration PROSPERO registration number: CRD42022331629. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022331629.
- Open Access
- 1 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Prevalence and Associated Risk Factors of Self-Harm Among Health Care Workers: Protocol for Systematic Review and Meta-Analysis (Preprint)
BACKGROUND Self-harm is a major public health concern, with prevalence increasing worldwide, particularly after the COVID-19 pandemic and associated lockdown restrictions. Health care workers (HCWs) face various challenges, such as pressures of social and familial responsibilities, a lack of integration within the profession, heavier workload, bullying at the workplace, and limited support in the workplace, that impact their mental health and often lead to self-harm. OBJECTIVE We aim to synthesize the evidence on the pooled prevalence of self-harm worldwide and identify risk factors for self-harm among HCWs. METHODS We will conduct a systematic review of observational and experimental studies that investigated the overall prevalence of self-harm among HCWs. We will search the PubMed, PsycINFO, Embase, and CINAHL databases for eligible articles from inception until March 2025 using specific search terms developed using the population, exposure, comparison, and outcome framework. Study selection and reporting will follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and the Meta-Analysis of Observational Studies in Epidemiology guidelines. We will contact the corresponding author via email if the required data are not available in the article. After completing the article search, duplicate records will be removed. Titles and abstracts will then be screened according to the inclusion and exclusion criteria, followed by retrieval of the full texts for detailed screening. All the required data for the review, such as names of authors, publication year, prevalence of self-harm, type of profession, associated risk factors to self-harm, and others, will be extracted using a standardized data extraction form. The quality of the studies will be assessed using the Joanna Briggs Institute guidelines based on the study design. Random-effects meta-analysis will be used to derive the pooled prevalence using Stata (version 17.0) software. We will conduct a subgroup meta-analysis on sex, regions, and the type of profession (physicians or nurses). We will also examine the association of risk factors of self-harm with sociodemographic factors to observe their relationship. Both analyses will be performed using RevMan software. Publication bias will be examined using the funnel plot and Egger test. RESULTS Data analysis is expected to be completed by August 2025, and manuscript preparation is expected to be completed by October 2025. This review is expected to be completed and published by January 2026. CONCLUSIONS We will provide a comprehensive synthesis of the overall prevalence of self-harm among HCWs. We will also provide important information to develop effective strategies for preventing and managing self-harm among HCWs. CLINICALTRIAL PROSPERO CRD42024581791; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024581791 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/67059
- 1 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPrevalence and Associated Risk Factors of Self-Harm Among Health Care Workers: Protocol for Systematic Review and Meta-Analysis (Preprint)
BACKGROUND Self-harm is a major public health concern, with prevalence increasing worldwide, particularly after the COVID-19 pandemic and associated lockdown restrictions. Health care workers (HCWs) face various challenges, such as pressures of social and familial responsibilities, a lack of integration within the profession, heavier workload, bullying at the workplace, and limited support in the workplace, that impact their mental health and often lead to self-harm. OBJECTIVE We aim to synthesize the evidence on the pooled prevalence of self-harm worldwide and identify risk factors for self-harm among HCWs. METHODS We will conduct a systematic review of observational and experimental studies that investigated the overall prevalence of self-harm among HCWs. We will search the PubMed, PsycINFO, Embase, and CINAHL databases for eligible articles from inception until March 2025 using specific search terms developed using the population, exposure, comparison, and outcome framework. Study selection and reporting will follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and the Meta-Analysis of Observational Studies in Epidemiology guidelines. We will contact the corresponding author via email if the required data are not available in the article. After completing the article search, duplicate records will be removed. Titles and abstracts will then be screened according to the inclusion and exclusion criteria, followed by retrieval of the full texts for detailed screening. All the required data for the review, such as names of authors, publication year, prevalence of self-harm, type of profession, associated risk factors to self-harm, and others, will be extracted using a standardized data extraction form. The quality of the studies will be assessed using the Joanna Briggs Institute guidelines based on the study design. Random-effects meta-analysis will be used to derive the pooled prevalence using Stata (version 17.0) software. We will conduct a subgroup meta-analysis on sex, regions, and the type of profession (physicians or nurses). We will also examine the association of risk factors of self-harm with sociodemographic factors to observe their relationship. Both analyses will be performed using RevMan software. Publication bias will be examined using the funnel plot and Egger test. RESULTS Data analysis is expected to be completed by August 2025, and manuscript preparation is expected to be completed by October 2025. This review is expected to be completed and published by January 2026. CONCLUSIONS We will provide a comprehensive synthesis of the overall prevalence of self-harm among HCWs. We will also provide important information to develop effective strategies for preventing and managing self-harm among HCWs. CLINICALTRIAL PROSPERO CRD42024581791; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024581791 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/67059
- Open Access
- 8 July 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Use of Naltrexone for Patients With Stimulant Use Disorder in Malaysia: Protocol for a Retrospective Cohort Study (Preprint)
BACKGROUND Naltrexone is an opioid receptor antagonist. Naltrexone is used to block the euphoric and sedative effects of drugs such as heroin, codeine, and morphine. The medication helps to bind and block opioid receptors to decrease opioid cravings. In Malaysia, naltrexone has been used for maintenance treatments for heroin and alcohol since 1996. However, since 2011, naltrexone has been used as an off-label stimulant use disorder (StUD) treatment to achieve abstinence. OBJECTIVE This study aims to determine the abstinence among StUD and non-StUD patients treated and without naltrexone. METHODS We will conduct a retrospective cohort study on the effect of naltrexone or treatment as usual (TAU) by examining the data for both StUD and non-StUD patients. We will use patients’ clinical records from the hospital registry. All adult patients (aged 18-65 years) diagnosed with StUD or other substance use disorders who were treated with naltrexone and standard care from January 1, 2011, to December 31, 2023, will be screened. All StUD and non-StUD patients who were offered the naltrexone treatment or TAU at the beginning of treatment will be recruited. All data will be extracted using a standardized data extraction form. Descriptive analysis will be performed to describe the distribution of patient characteristics, sociodemographic profiles, and percentages of abstinence and treatment retention. We will conduct univariable analysis to determine the association of stimulant abstinence and treatment retention between naltrexone and TAU among both StUD and non-StUD patients. All significant independent variables will be further analyzed using a cross-sectional time series method for categorical variables. RESULTS Recruitment began in July 2025. Data analysis will begin after completing data collection, planned for January 2026. CONCLUSIONS The expected main outcome of this study is to observe the significant associations of stimulant use abstinence and treatment retention between TAU and naltrexone among StUD and non-StUD patients. The findings from this study may provide preliminary evidence regarding the use of naltrexone in treating StUD. Currently, there is no specific medication to treat amphetamine or methamphetamine use disorder. The effect of naltrexone with psychosocial interventions for StUD is unclear. Public health approaches recognize the multifaceted nature of substance misuse and focus on addressing the myriad individual, environmental, and social factors that contribute to StUD. CLINICALTRIAL INTERNATIONAL REGISTERED REPORT PRR1-10.2196/64101
- 8 July 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUse of Naltrexone for Patients With Stimulant Use Disorder in Malaysia: Protocol for a Retrospective Cohort Study (Preprint)
BACKGROUND Naltrexone is an opioid receptor antagonist. Naltrexone is used to block the euphoric and sedative effects of drugs such as heroin, codeine, and morphine. The medication helps to bind and block opioid receptors to decrease opioid cravings. In Malaysia, naltrexone has been used for maintenance treatments for heroin and alcohol since 1996. However, since 2011, naltrexone has been used as an off-label stimulant use disorder (StUD) treatment to achieve abstinence. OBJECTIVE This study aims to determine the abstinence among StUD and non-StUD patients treated and without naltrexone. METHODS We will conduct a retrospective cohort study on the effect of naltrexone or treatment as usual (TAU) by examining the data for both StUD and non-StUD patients. We will use patients’ clinical records from the hospital registry. All adult patients (aged 18-65 years) diagnosed with StUD or other substance use disorders who were treated with naltrexone and standard care from January 1, 2011, to December 31, 2023, will be screened. All StUD and non-StUD patients who were offered the naltrexone treatment or TAU at the beginning of treatment will be recruited. All data will be extracted using a standardized data extraction form. Descriptive analysis will be performed to describe the distribution of patient characteristics, sociodemographic profiles, and percentages of abstinence and treatment retention. We will conduct univariable analysis to determine the association of stimulant abstinence and treatment retention between naltrexone and TAU among both StUD and non-StUD patients. All significant independent variables will be further analyzed using a cross-sectional time series method for categorical variables. RESULTS Recruitment began in July 2025. Data analysis will begin after completing data collection, planned for January 2026. CONCLUSIONS The expected main outcome of this study is to observe the significant associations of stimulant use abstinence and treatment retention between TAU and naltrexone among StUD and non-StUD patients. The findings from this study may provide preliminary evidence regarding the use of naltrexone in treating StUD. Currently, there is no specific medication to treat amphetamine or methamphetamine use disorder. The effect of naltrexone with psychosocial interventions for StUD is unclear. Public health approaches recognize the multifaceted nature of substance misuse and focus on addressing the myriad individual, environmental, and social factors that contribute to StUD. CLINICALTRIAL INTERNATIONAL REGISTERED REPORT PRR1-10.2196/64101